NSC |
Compound |
Enrichment |
Correlation |
NSC 703467 |
Null |
0.0107933723273943 |
0.49231649 |
NSC 711745 |
Null |
0.0107933723273943 |
0.38512346 |
NSC 725191 |
1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol |
0.0107933723273943 |
0.47740197 |
NSC 726262 |
1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one |
0.0107933723273943 |
0.33699875 |
NSC 737613 |
Null |
0.0107933723273943 |
0.33914192 |
NSC 740385 |
7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide |
0.0107933723273943 |
0.45482832 |
NSC 749379 |
Null |
0.0107933723273943 |
0.37543772 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.0107933723273943 |
0.65723546 |
NSC 140380 |
Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) |
0.0110679092462696 |
0.33109852 |
NSC 265211 |
NSC 265211 |
0.0110679092462696 |
0.22406855 |